Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 27 April 2009, doi:10.1136/bmj.b1715
Cite this as: BMJ 2009;338:b1715
| The first 150 words of the full text of this article appear below. |
Flu vaccination rates vary across Europe: Coverage of influenza vaccination varies widely between countries, a study has shown (Journal of Infection 2009 Apr 17, doi:10.1016/j.jinf.2009.04.001). Coverage varied from 9.5% in Poland to 28.7% in the United Kingdom in 2007-8. Coverage in the elderly people was most in the UK, at 70.2%, and vaccine uptake in children was lowest in Ireland (4.2%) and highest in Germany (19.3%).
Managing bladder problems in multiple sclerosis: Second line treatments, such as bladder injections of botulinum toxin A and intermittent self catheterisation, should be more widely available to people with multiple sclerosis who have bladder problems, says evidence based guidance from a multidisciplinary expert group (Journal of Neurology, Neurosurgery and Psychiatry 2009;80:470-7, doi:10.1136/jnnp.2008.159178). The guidance sets out who should see patients who have multiple sclerosis at different stages of their condition and what investigations and treatments should be available.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?